CD4 and neoplasm: To identify tumor-specific clones that recognize Ep63K neo-antigen or native B16 antigens, we immortalized CD4+Teffs and Tregs sorted from tumor mass or tumor draining lymph nodes of both untreated and DTA-1 treated TCRmini mice.